High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
NCT00034242
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
NIH
Sponsor class
Conditions
Spinocerebellar Degenerations
Interventions
DRUG:
high-dose intravenous immunoglobulin (IVIG)
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)